nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—CYP2D6—breast cancer	0.149	0.538	CbGaD
Proguanil—CYP3A4—breast cancer	0.128	0.462	CbGaD
Proguanil—DHFR—Methotrexate—breast cancer	0.0667	0.136	CbGbCtD
Proguanil—CYP1A2—Anastrozole—breast cancer	0.0301	0.0611	CbGbCtD
Proguanil—CYP1A2—Toremifene—breast cancer	0.0275	0.0559	CbGbCtD
Proguanil—CYP2C9—Anastrozole—breast cancer	0.0271	0.0551	CbGbCtD
Proguanil—CYP2C19—Lapatinib—breast cancer	0.0218	0.0442	CbGbCtD
Proguanil—CYP3A4—Exemestane—breast cancer	0.0208	0.0422	CbGbCtD
Proguanil—CYP2C9—Idarubicin—breast cancer	0.0205	0.0417	CbGbCtD
Proguanil—CYP2D6—Idarubicin—breast cancer	0.0188	0.0382	CbGbCtD
Proguanil—CYP3A4—Letrozole—breast cancer	0.0177	0.0359	CbGbCtD
Proguanil—CYP2E1—Tamoxifen—breast cancer	0.0174	0.0353	CbGbCtD
Proguanil—CYP2E1—Mitoxantrone—breast cancer	0.0169	0.0344	CbGbCtD
Proguanil—CYP3A4—Anastrozole—breast cancer	0.0158	0.032	CbGbCtD
Proguanil—CYP3A4—Toremifene—breast cancer	0.0144	0.0293	CbGbCtD
Proguanil—CYP3A4—Fulvestrant—breast cancer	0.0134	0.0272	CbGbCtD
Proguanil—CYP3A4—Thiotepa—breast cancer	0.0119	0.0243	CbGbCtD
Proguanil—CYP2C9—Capecitabine—breast cancer	0.0113	0.0229	CbGbCtD
Proguanil—CYP3A4—Ixabepilone—breast cancer	0.0109	0.0222	CbGbCtD
Proguanil—CYP2C19—Tamoxifen—breast cancer	0.0109	0.0221	CbGbCtD
Proguanil—CYP3A4—Lapatinib—breast cancer	0.0105	0.0214	CbGbCtD
Proguanil—CYP1A2—Tamoxifen—breast cancer	0.0101	0.0204	CbGbCtD
Proguanil—CYP2D6—Vinorelbine—breast cancer	0.00917	0.0186	CbGbCtD
Proguanil—CYP2C9—Tamoxifen—breast cancer	0.00906	0.0184	CbGbCtD
Proguanil—CYP2D6—Tamoxifen—breast cancer	0.00828	0.0168	CbGbCtD
Proguanil—CYP3A4—Raloxifene—breast cancer	0.00797	0.0162	CbGbCtD
Proguanil—CYP1A2—Fluorouracil—breast cancer	0.00741	0.015	CbGbCtD
Proguanil—CYP2C9—Paclitaxel—breast cancer	0.00705	0.0143	CbGbCtD
Proguanil—CYP2C9—Fluorouracil—breast cancer	0.00667	0.0136	CbGbCtD
Proguanil—CYP3A4—Vinorelbine—breast cancer	0.00583	0.0118	CbGbCtD
Proguanil—CYP2D6—Vinblastine—breast cancer	0.00565	0.0115	CbGbCtD
Proguanil—CYP3A4—Tamoxifen—breast cancer	0.00527	0.0107	CbGbCtD
Proguanil—CYP3A4—Mitoxantrone—breast cancer	0.00514	0.0104	CbGbCtD
Proguanil—CYP3A4—Paclitaxel—breast cancer	0.0041	0.00832	CbGbCtD
Proguanil—CYP3A4—Irinotecan—breast cancer	0.00404	0.00821	CbGbCtD
Proguanil—CYP3A4—Vinblastine—breast cancer	0.00359	0.0073	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—breast cancer	0.00347	0.00706	CbGbCtD
Proguanil—CYP3A4—Docetaxel—breast cancer	0.00296	0.00602	CbGbCtD
Proguanil—CYP3A4—Doxorubicin—breast cancer	0.00221	0.00449	CbGbCtD
Proguanil—DHFR—nipple—breast cancer	0.000536	0.101	CbGeAlD
Proguanil—DHFR—embryo—breast cancer	0.000442	0.0833	CbGeAlD
Proguanil—DHFR—endometrium—breast cancer	0.000324	0.061	CbGeAlD
Proguanil—DHFR—uterus—breast cancer	0.000298	0.0562	CbGeAlD
Proguanil—DHFR—pituitary gland—breast cancer	0.000293	0.0552	CbGeAlD
Proguanil—DHFR—adipose tissue—breast cancer	0.000292	0.0549	CbGeAlD
Proguanil—CYP2C9—mammary gland—breast cancer	0.000286	0.0538	CbGeAlD
Proguanil—DHFR—female reproductive system—breast cancer	0.000268	0.0505	CbGeAlD
Proguanil—DHFR—adrenal gland—breast cancer	0.000262	0.0493	CbGeAlD
Proguanil—DHFR—bone marrow—breast cancer	0.000253	0.0477	CbGeAlD
Proguanil—CYP1A2—nipple—breast cancer	0.000249	0.0469	CbGeAlD
Proguanil—DHFR—female gonad—breast cancer	0.000244	0.046	CbGeAlD
Proguanil—DHFR—endocrine gland—breast cancer	0.000227	0.0427	CbGeAlD
Proguanil—Nausea—Idarubicin—breast cancer	0.000212	0.00167	CcSEcCtD
Proguanil—Gastrointestinal pain—Tamoxifen—breast cancer	0.00021	0.00166	CcSEcCtD
Proguanil—Anorexia—Vinorelbine—breast cancer	0.00021	0.00165	CcSEcCtD
Proguanil—Pancytopenia—Docetaxel—breast cancer	0.000209	0.00165	CcSEcCtD
Proguanil—Abdominal pain—Vinblastine—breast cancer	0.000209	0.00165	CcSEcCtD
Proguanil—Nervous system disorder—Thiotepa—breast cancer	0.000206	0.00162	CcSEcCtD
Proguanil—Skin disorder—Thiotepa—breast cancer	0.000204	0.00161	CcSEcCtD
Proguanil—Abdominal pain—Tamoxifen—breast cancer	0.000203	0.0016	CcSEcCtD
Proguanil—Pancytopenia—Capecitabine—breast cancer	0.000203	0.0016	CcSEcCtD
Proguanil—Gastrointestinal pain—Goserelin—breast cancer	0.000201	0.00158	CcSEcCtD
Proguanil—Anorexia—Thiotepa—breast cancer	0.0002	0.00158	CcSEcCtD
Proguanil—Diarrhoea—Chlorambucil—breast cancer	0.000197	0.00156	CcSEcCtD
Proguanil—Abdominal pain—Goserelin—breast cancer	0.000194	0.00153	CcSEcCtD
Proguanil—Body temperature increased—Goserelin—breast cancer	0.000194	0.00153	CcSEcCtD
Proguanil—Cough—Mitoxantrone—breast cancer	0.000194	0.00153	CcSEcCtD
Proguanil—Cough—Irinotecan—breast cancer	0.000194	0.00153	CcSEcCtD
Proguanil—Stomatitis—Docetaxel—breast cancer	0.000192	0.00151	CcSEcCtD
Proguanil—Decreased appetite—Vinorelbine—breast cancer	0.000191	0.00151	CcSEcCtD
Proguanil—Gastrointestinal disorder—Vinorelbine—breast cancer	0.00019	0.0015	CcSEcCtD
Proguanil—Cough—Gemcitabine—breast cancer	0.000189	0.00149	CcSEcCtD
Proguanil—Immune system disorder—Paclitaxel—breast cancer	0.000188	0.00148	CcSEcCtD
Proguanil—Mediastinal disorder—Paclitaxel—breast cancer	0.000188	0.00148	CcSEcCtD
Proguanil—Hepatobiliary disease—Docetaxel—breast cancer	0.000186	0.00147	CcSEcCtD
Proguanil—Stomatitis—Capecitabine—breast cancer	0.000185	0.00146	CcSEcCtD
Proguanil—Vomiting—Chlorambucil—breast cancer	0.000184	0.00145	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000183	0.00144	CcSEcCtD
Proguanil—Decreased appetite—Thiotepa—breast cancer	0.000182	0.00144	CcSEcCtD
Proguanil—Mental disorder—Paclitaxel—breast cancer	0.000182	0.00144	CcSEcCtD
Proguanil—Gastrointestinal disorder—Thiotepa—breast cancer	0.000181	0.00143	CcSEcCtD
Proguanil—Malnutrition—Paclitaxel—breast cancer	0.000181	0.00143	CcSEcCtD
Proguanil—Erythema—Paclitaxel—breast cancer	0.000181	0.00143	CcSEcCtD
Proguanil—Diarrhoea—Vinblastine—breast cancer	0.000181	0.00143	CcSEcCtD
Proguanil—Hepatobiliary disease—Capecitabine—breast cancer	0.00018	0.00142	CcSEcCtD
Proguanil—Gastrointestinal pain—Vinorelbine—breast cancer	0.00018	0.00142	CcSEcCtD
Proguanil—Nervous system disorder—Irinotecan—breast cancer	0.000178	0.0014	CcSEcCtD
Proguanil—Skin disorder—Mitoxantrone—breast cancer	0.000176	0.00139	CcSEcCtD
Proguanil—Diarrhoea—Tamoxifen—breast cancer	0.000176	0.00139	CcSEcCtD
Proguanil—Abdominal pain—Vinorelbine—breast cancer	0.000174	0.00137	CcSEcCtD
Proguanil—Body temperature increased—Vinorelbine—breast cancer	0.000174	0.00137	CcSEcCtD
Proguanil—Nervous system disorder—Gemcitabine—breast cancer	0.000173	0.00137	CcSEcCtD
Proguanil—Anorexia—Mitoxantrone—breast cancer	0.000173	0.00136	CcSEcCtD
Proguanil—Anorexia—Irinotecan—breast cancer	0.000173	0.00136	CcSEcCtD
Proguanil—Diarrhoea—Melphalan—breast cancer	0.000172	0.00136	CcSEcCtD
Proguanil—Gastrointestinal pain—Thiotepa—breast cancer	0.000172	0.00135	CcSEcCtD
Proguanil—Skin disorder—Gemcitabine—breast cancer	0.000172	0.00135	CcSEcCtD
Proguanil—Nausea—Chlorambucil—breast cancer	0.000171	0.00135	CcSEcCtD
Proguanil—Nervous system disorder—Fluorouracil—breast cancer	0.00017	0.00134	CcSEcCtD
Proguanil—Anorexia—Gemcitabine—breast cancer	0.000168	0.00133	CcSEcCtD
Proguanil—Vomiting—Vinblastine—breast cancer	0.000168	0.00133	CcSEcCtD
Proguanil—Diarrhoea—Goserelin—breast cancer	0.000168	0.00132	CcSEcCtD
Proguanil—Abdominal pain—Thiotepa—breast cancer	0.000166	0.00131	CcSEcCtD
Proguanil—Body temperature increased—Thiotepa—breast cancer	0.000166	0.00131	CcSEcCtD
Proguanil—Headache—Vinblastine—breast cancer	0.000166	0.00131	CcSEcCtD
Proguanil—Anorexia—Fluorouracil—breast cancer	0.000165	0.00131	CcSEcCtD
Proguanil—Vomiting—Tamoxifen—breast cancer	0.000163	0.00129	CcSEcCtD
Proguanil—Rash—Tamoxifen—breast cancer	0.000162	0.00128	CcSEcCtD
Proguanil—Dermatitis—Tamoxifen—breast cancer	0.000162	0.00128	CcSEcCtD
Proguanil—Headache—Tamoxifen—breast cancer	0.000161	0.00127	CcSEcCtD
Proguanil—Vomiting—Melphalan—breast cancer	0.00016	0.00126	CcSEcCtD
Proguanil—Immune system disorder—Docetaxel—breast cancer	0.000159	0.00126	CcSEcCtD
Proguanil—Mediastinal disorder—Docetaxel—breast cancer	0.000159	0.00125	CcSEcCtD
Proguanil—Rash—Melphalan—breast cancer	0.000159	0.00125	CcSEcCtD
Proguanil—Dermatitis—Melphalan—breast cancer	0.000158	0.00125	CcSEcCtD
Proguanil—Cough—Paclitaxel—breast cancer	0.000158	0.00125	CcSEcCtD
Proguanil—Decreased appetite—Mitoxantrone—breast cancer	0.000158	0.00124	CcSEcCtD
Proguanil—Decreased appetite—Irinotecan—breast cancer	0.000158	0.00124	CcSEcCtD
Proguanil—Nausea—Vinblastine—breast cancer	0.000157	0.00124	CcSEcCtD
Proguanil—DHFR—lymph node—breast cancer	0.000157	0.0295	CbGeAlD
Proguanil—Gastrointestinal disorder—Irinotecan—breast cancer	0.000157	0.00123	CcSEcCtD
Proguanil—Vomiting—Goserelin—breast cancer	0.000156	0.00123	CcSEcCtD
Proguanil—Rash—Goserelin—breast cancer	0.000155	0.00122	CcSEcCtD
Proguanil—Dermatitis—Goserelin—breast cancer	0.000155	0.00122	CcSEcCtD
Proguanil—Mental disorder—Docetaxel—breast cancer	0.000155	0.00122	CcSEcCtD
Proguanil—Immune system disorder—Capecitabine—breast cancer	0.000154	0.00122	CcSEcCtD
Proguanil—Mediastinal disorder—Capecitabine—breast cancer	0.000154	0.00121	CcSEcCtD
Proguanil—Headache—Goserelin—breast cancer	0.000154	0.00121	CcSEcCtD
Proguanil—Erythema—Docetaxel—breast cancer	0.000154	0.00121	CcSEcCtD
Proguanil—Malnutrition—Docetaxel—breast cancer	0.000154	0.00121	CcSEcCtD
Proguanil—Decreased appetite—Gemcitabine—breast cancer	0.000154	0.00121	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000153	0.00121	CcSEcCtD
Proguanil—Nausea—Tamoxifen—breast cancer	0.000153	0.0012	CcSEcCtD
Proguanil—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000152	0.0012	CcSEcCtD
Proguanil—Decreased appetite—Fluorouracil—breast cancer	0.000151	0.00119	CcSEcCtD
Proguanil—Pancytopenia—Methotrexate—breast cancer	0.000151	0.00119	CcSEcCtD
Proguanil—Diarrhoea—Vinorelbine—breast cancer	0.00015	0.00119	CcSEcCtD
Proguanil—Gastrointestinal disorder—Fluorouracil—breast cancer	0.00015	0.00118	CcSEcCtD
Proguanil—Mental disorder—Capecitabine—breast cancer	0.00015	0.00118	CcSEcCtD
Proguanil—Nausea—Melphalan—breast cancer	0.000149	0.00118	CcSEcCtD
Proguanil—Erythema—Capecitabine—breast cancer	0.000149	0.00117	CcSEcCtD
Proguanil—Malnutrition—Capecitabine—breast cancer	0.000149	0.00117	CcSEcCtD
Proguanil—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000148	0.00117	CcSEcCtD
Proguanil—Gastrointestinal pain—Irinotecan—breast cancer	0.000148	0.00117	CcSEcCtD
Proguanil—Nausea—Goserelin—breast cancer	0.000146	0.00115	CcSEcCtD
Proguanil—Nervous system disorder—Paclitaxel—breast cancer	0.000145	0.00114	CcSEcCtD
Proguanil—Diarrhoea—Thiotepa—breast cancer	0.000144	0.00113	CcSEcCtD
Proguanil—Skin disorder—Paclitaxel—breast cancer	0.000144	0.00113	CcSEcCtD
Proguanil—Abdominal pain—Mitoxantrone—breast cancer	0.000143	0.00113	CcSEcCtD
Proguanil—Body temperature increased—Irinotecan—breast cancer	0.000143	0.00113	CcSEcCtD
Proguanil—Body temperature increased—Mitoxantrone—breast cancer	0.000143	0.00113	CcSEcCtD
Proguanil—Abdominal pain—Irinotecan—breast cancer	0.000143	0.00113	CcSEcCtD
Proguanil—Pancytopenia—Epirubicin—breast cancer	0.000141	0.00111	CcSEcCtD
Proguanil—Anorexia—Paclitaxel—breast cancer	0.000141	0.00111	CcSEcCtD
Proguanil—Vomiting—Vinorelbine—breast cancer	0.00014	0.0011	CcSEcCtD
Proguanil—Body temperature increased—Gemcitabine—breast cancer	0.00014	0.0011	CcSEcCtD
Proguanil—Rash—Vinorelbine—breast cancer	0.000139	0.00109	CcSEcCtD
Proguanil—Dermatitis—Vinorelbine—breast cancer	0.000138	0.00109	CcSEcCtD
Proguanil—Stomatitis—Methotrexate—breast cancer	0.000138	0.00109	CcSEcCtD
Proguanil—Headache—Vinorelbine—breast cancer	0.000138	0.00109	CcSEcCtD
Proguanil—Body temperature increased—Fluorouracil—breast cancer	0.000137	0.00108	CcSEcCtD
Proguanil—Cough—Docetaxel—breast cancer	0.000134	0.00106	CcSEcCtD
Proguanil—Hepatobiliary disease—Methotrexate—breast cancer	0.000134	0.00106	CcSEcCtD
Proguanil—Vomiting—Thiotepa—breast cancer	0.000133	0.00105	CcSEcCtD
Proguanil—Rash—Thiotepa—breast cancer	0.000132	0.00104	CcSEcCtD
Proguanil—Dermatitis—Thiotepa—breast cancer	0.000132	0.00104	CcSEcCtD
Proguanil—Headache—Thiotepa—breast cancer	0.000132	0.00104	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—breast cancer	0.000131	0.00103	CcSEcCtD
Proguanil—Nausea—Vinorelbine—breast cancer	0.000131	0.00103	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.00013	0.00102	CcSEcCtD
Proguanil—Cough—Capecitabine—breast cancer	0.00013	0.00102	CcSEcCtD
Proguanil—Stomatitis—Epirubicin—breast cancer	0.000129	0.00102	CcSEcCtD
Proguanil—CYP2C19—endocrine gland—breast cancer	0.000129	0.0243	CbGeAlD
Proguanil—Decreased appetite—Paclitaxel—breast cancer	0.000129	0.00101	CcSEcCtD
Proguanil—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000128	0.00101	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000126	0.000992	CcSEcCtD
Proguanil—Hepatobiliary disease—Epirubicin—breast cancer	0.000125	0.000989	CcSEcCtD
Proguanil—Nausea—Thiotepa—breast cancer	0.000125	0.000984	CcSEcCtD
Proguanil—Diarrhoea—Mitoxantrone—breast cancer	0.000124	0.000979	CcSEcCtD
Proguanil—Diarrhoea—Irinotecan—breast cancer	0.000124	0.000979	CcSEcCtD
Proguanil—Nervous system disorder—Docetaxel—breast cancer	0.000123	0.00097	CcSEcCtD
Proguanil—Skin disorder—Docetaxel—breast cancer	0.000122	0.00096	CcSEcCtD
Proguanil—Gastrointestinal pain—Paclitaxel—breast cancer	0.000121	0.000954	CcSEcCtD
Proguanil—Diarrhoea—Gemcitabine—breast cancer	0.000121	0.000953	CcSEcCtD
Proguanil—Stomatitis—Doxorubicin—breast cancer	0.00012	0.000943	CcSEcCtD
Proguanil—Anorexia—Docetaxel—breast cancer	0.000119	0.000943	CcSEcCtD
Proguanil—Nervous system disorder—Capecitabine—breast cancer	0.000119	0.000939	CcSEcCtD
Proguanil—Diarrhoea—Fluorouracil—breast cancer	0.000119	0.000937	CcSEcCtD
Proguanil—CYP2C9—female reproductive system—breast cancer	0.000118	0.0223	CbGeAlD
Proguanil—Skin disorder—Capecitabine—breast cancer	0.000118	0.00093	CcSEcCtD
Proguanil—Body temperature increased—Paclitaxel—breast cancer	0.000117	0.000922	CcSEcCtD
Proguanil—Abdominal pain—Paclitaxel—breast cancer	0.000117	0.000922	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—breast cancer	0.000116	0.000915	CcSEcCtD
Proguanil—Anorexia—Capecitabine—breast cancer	0.000116	0.000913	CcSEcCtD
Proguanil—Vomiting—Irinotecan—breast cancer	0.000115	0.000909	CcSEcCtD
Proguanil—Vomiting—Mitoxantrone—breast cancer	0.000115	0.000909	CcSEcCtD
Proguanil—Immune system disorder—Methotrexate—breast cancer	0.000115	0.000906	CcSEcCtD
Proguanil—Mediastinal disorder—Methotrexate—breast cancer	0.000115	0.000904	CcSEcCtD
Proguanil—Rash—Mitoxantrone—breast cancer	0.000114	0.000902	CcSEcCtD
Proguanil—Rash—Irinotecan—breast cancer	0.000114	0.000902	CcSEcCtD
Proguanil—Dermatitis—Irinotecan—breast cancer	0.000114	0.000901	CcSEcCtD
Proguanil—Dermatitis—Mitoxantrone—breast cancer	0.000114	0.000901	CcSEcCtD
Proguanil—Headache—Irinotecan—breast cancer	0.000114	0.000896	CcSEcCtD
Proguanil—Headache—Mitoxantrone—breast cancer	0.000114	0.000896	CcSEcCtD
Proguanil—Vomiting—Gemcitabine—breast cancer	0.000112	0.000886	CcSEcCtD
Proguanil—CYP2E1—female reproductive system—breast cancer	0.000112	0.0211	CbGeAlD
Proguanil—Mental disorder—Methotrexate—breast cancer	0.000111	0.000879	CcSEcCtD
Proguanil—Rash—Gemcitabine—breast cancer	0.000111	0.000879	CcSEcCtD
Proguanil—Dermatitis—Gemcitabine—breast cancer	0.000111	0.000878	CcSEcCtD
Proguanil—Malnutrition—Methotrexate—breast cancer	0.000111	0.000873	CcSEcCtD
Proguanil—Erythema—Methotrexate—breast cancer	0.000111	0.000873	CcSEcCtD
Proguanil—Headache—Gemcitabine—breast cancer	0.000111	0.000873	CcSEcCtD
Proguanil—Vomiting—Fluorouracil—breast cancer	0.00011	0.000871	CcSEcCtD
Proguanil—Rash—Fluorouracil—breast cancer	0.000109	0.000864	CcSEcCtD
Proguanil—Dermatitis—Fluorouracil—breast cancer	0.000109	0.000863	CcSEcCtD
Proguanil—CYP2E1—adrenal gland—breast cancer	0.000109	0.0206	CbGeAlD
Proguanil—Decreased appetite—Docetaxel—breast cancer	0.000109	0.00086	CcSEcCtD
Proguanil—Headache—Fluorouracil—breast cancer	0.000109	0.000858	CcSEcCtD
Proguanil—Gastrointestinal disorder—Docetaxel—breast cancer	0.000108	0.000854	CcSEcCtD
Proguanil—Nausea—Irinotecan—breast cancer	0.000108	0.00085	CcSEcCtD
Proguanil—Nausea—Mitoxantrone—breast cancer	0.000108	0.00085	CcSEcCtD
Proguanil—Immune system disorder—Epirubicin—breast cancer	0.000107	0.000848	CcSEcCtD
Proguanil—Mediastinal disorder—Epirubicin—breast cancer	0.000107	0.000846	CcSEcCtD
Proguanil—Decreased appetite—Capecitabine—breast cancer	0.000105	0.000832	CcSEcCtD
Proguanil—CYP1A2—endocrine gland—breast cancer	0.000105	0.0199	CbGeAlD
Proguanil—Nausea—Gemcitabine—breast cancer	0.000105	0.000828	CcSEcCtD
Proguanil—Gastrointestinal disorder—Capecitabine—breast cancer	0.000105	0.000826	CcSEcCtD
Proguanil—Mental disorder—Epirubicin—breast cancer	0.000104	0.000822	CcSEcCtD
Proguanil—Erythema—Epirubicin—breast cancer	0.000104	0.000817	CcSEcCtD
Proguanil—Malnutrition—Epirubicin—breast cancer	0.000104	0.000817	CcSEcCtD
Proguanil—Nausea—Fluorouracil—breast cancer	0.000103	0.000814	CcSEcCtD
Proguanil—Gastrointestinal pain—Docetaxel—breast cancer	0.000102	0.000809	CcSEcCtD
Proguanil—Diarrhoea—Paclitaxel—breast cancer	0.000101	0.000798	CcSEcCtD
Proguanil—CYP2C9—endocrine gland—breast cancer	0.0001	0.0188	CbGeAlD
Proguanil—Immune system disorder—Doxorubicin—breast cancer	9.94e-05	0.000785	CcSEcCtD
Proguanil—Gastrointestinal pain—Capecitabine—breast cancer	9.92e-05	0.000783	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—breast cancer	9.92e-05	0.000783	CcSEcCtD
Proguanil—Body temperature increased—Docetaxel—breast cancer	9.91e-05	0.000782	CcSEcCtD
Proguanil—Abdominal pain—Docetaxel—breast cancer	9.91e-05	0.000782	CcSEcCtD
Proguanil—Cough—Methotrexate—breast cancer	9.66e-05	0.000762	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—breast cancer	9.64e-05	0.000761	CcSEcCtD
Proguanil—Abdominal pain—Capecitabine—breast cancer	9.59e-05	0.000757	CcSEcCtD
Proguanil—Body temperature increased—Capecitabine—breast cancer	9.59e-05	0.000757	CcSEcCtD
Proguanil—Erythema—Doxorubicin—breast cancer	9.58e-05	0.000756	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—breast cancer	9.58e-05	0.000756	CcSEcCtD
Proguanil—CYP2E1—endocrine gland—breast cancer	9.48e-05	0.0179	CbGeAlD
Proguanil—Vomiting—Paclitaxel—breast cancer	9.4e-05	0.000742	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	9.36e-05	0.000738	CcSEcCtD
Proguanil—Rash—Paclitaxel—breast cancer	9.32e-05	0.000736	CcSEcCtD
Proguanil—Dermatitis—Paclitaxel—breast cancer	9.31e-05	0.000735	CcSEcCtD
Proguanil—Headache—Paclitaxel—breast cancer	9.26e-05	0.000731	CcSEcCtD
Proguanil—Cough—Epirubicin—breast cancer	9.04e-05	0.000713	CcSEcCtD
Proguanil—CYP3A4—female reproductive system—breast cancer	9.02e-05	0.017	CbGeAlD
Proguanil—CYP2D6—female reproductive system—breast cancer	8.87e-05	0.0167	CbGeAlD
Proguanil—Nervous system disorder—Methotrexate—breast cancer	8.86e-05	0.000699	CcSEcCtD
Proguanil—Nausea—Paclitaxel—breast cancer	8.78e-05	0.000693	CcSEcCtD
Proguanil—Skin disorder—Methotrexate—breast cancer	8.77e-05	0.000692	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.76e-05	0.000691	CcSEcCtD
Proguanil—Anorexia—Methotrexate—breast cancer	8.61e-05	0.000679	CcSEcCtD
Proguanil—Diarrhoea—Docetaxel—breast cancer	8.57e-05	0.000677	CcSEcCtD
Proguanil—Cough—Doxorubicin—breast cancer	8.36e-05	0.00066	CcSEcCtD
Proguanil—Diarrhoea—Capecitabine—breast cancer	8.3e-05	0.000655	CcSEcCtD
Proguanil—Nervous system disorder—Epirubicin—breast cancer	8.29e-05	0.000654	CcSEcCtD
Proguanil—Skin disorder—Epirubicin—breast cancer	8.21e-05	0.000648	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	8.1e-05	0.000639	CcSEcCtD
Proguanil—CYP2D6—female gonad—breast cancer	8.07e-05	0.0152	CbGeAlD
Proguanil—Anorexia—Epirubicin—breast cancer	8.06e-05	0.000636	CcSEcCtD
Proguanil—Vomiting—Docetaxel—breast cancer	7.97e-05	0.000629	CcSEcCtD
Proguanil—Rash—Docetaxel—breast cancer	7.9e-05	0.000623	CcSEcCtD
Proguanil—Dermatitis—Docetaxel—breast cancer	7.89e-05	0.000623	CcSEcCtD
Proguanil—Decreased appetite—Methotrexate—breast cancer	7.85e-05	0.000619	CcSEcCtD
Proguanil—Headache—Docetaxel—breast cancer	7.85e-05	0.000619	CcSEcCtD
Proguanil—Gastrointestinal disorder—Methotrexate—breast cancer	7.8e-05	0.000615	CcSEcCtD
Proguanil—Vomiting—Capecitabine—breast cancer	7.71e-05	0.000609	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—breast cancer	7.67e-05	0.000605	CcSEcCtD
Proguanil—Rash—Capecitabine—breast cancer	7.65e-05	0.000604	CcSEcCtD
Proguanil—Dermatitis—Capecitabine—breast cancer	7.64e-05	0.000603	CcSEcCtD
Proguanil—CYP3A4—endocrine gland—breast cancer	7.63e-05	0.0144	CbGeAlD
Proguanil—Headache—Capecitabine—breast cancer	7.6e-05	0.0006	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—breast cancer	7.6e-05	0.000599	CcSEcCtD
Proguanil—CYP2D6—endocrine gland—breast cancer	7.51e-05	0.0141	CbGeAlD
Proguanil—Anorexia—Doxorubicin—breast cancer	7.45e-05	0.000588	CcSEcCtD
Proguanil—Nausea—Docetaxel—breast cancer	7.44e-05	0.000587	CcSEcCtD
Proguanil—Gastrointestinal pain—Methotrexate—breast cancer	7.39e-05	0.000583	CcSEcCtD
Proguanil—Decreased appetite—Epirubicin—breast cancer	7.35e-05	0.00058	CcSEcCtD
Proguanil—Gastrointestinal disorder—Epirubicin—breast cancer	7.3e-05	0.000576	CcSEcCtD
Proguanil—Nausea—Capecitabine—breast cancer	7.21e-05	0.000569	CcSEcCtD
Proguanil—Abdominal pain—Methotrexate—breast cancer	7.14e-05	0.000563	CcSEcCtD
Proguanil—Body temperature increased—Methotrexate—breast cancer	7.14e-05	0.000563	CcSEcCtD
Proguanil—Gastrointestinal pain—Epirubicin—breast cancer	6.91e-05	0.000545	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—breast cancer	6.8e-05	0.000536	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—breast cancer	6.75e-05	0.000533	CcSEcCtD
Proguanil—Abdominal pain—Epirubicin—breast cancer	6.68e-05	0.000527	CcSEcCtD
Proguanil—Body temperature increased—Epirubicin—breast cancer	6.68e-05	0.000527	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—breast cancer	6.4e-05	0.000505	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—breast cancer	6.18e-05	0.000488	CcSEcCtD
Proguanil—Body temperature increased—Doxorubicin—breast cancer	6.18e-05	0.000488	CcSEcCtD
Proguanil—Diarrhoea—Methotrexate—breast cancer	6.18e-05	0.000488	CcSEcCtD
Proguanil—Diarrhoea—Epirubicin—breast cancer	5.78e-05	0.000456	CcSEcCtD
Proguanil—Vomiting—Methotrexate—breast cancer	5.74e-05	0.000453	CcSEcCtD
Proguanil—Rash—Methotrexate—breast cancer	5.69e-05	0.000449	CcSEcCtD
Proguanil—Dermatitis—Methotrexate—breast cancer	5.69e-05	0.000449	CcSEcCtD
Proguanil—Headache—Methotrexate—breast cancer	5.66e-05	0.000446	CcSEcCtD
Proguanil—Vomiting—Epirubicin—breast cancer	5.37e-05	0.000424	CcSEcCtD
Proguanil—Nausea—Methotrexate—breast cancer	5.36e-05	0.000423	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—breast cancer	5.35e-05	0.000422	CcSEcCtD
Proguanil—Rash—Epirubicin—breast cancer	5.33e-05	0.000421	CcSEcCtD
Proguanil—Dermatitis—Epirubicin—breast cancer	5.32e-05	0.00042	CcSEcCtD
Proguanil—Headache—Epirubicin—breast cancer	5.3e-05	0.000418	CcSEcCtD
Proguanil—Nausea—Epirubicin—breast cancer	5.02e-05	0.000396	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—breast cancer	4.97e-05	0.000392	CcSEcCtD
Proguanil—Rash—Doxorubicin—breast cancer	4.93e-05	0.000389	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—breast cancer	4.93e-05	0.000389	CcSEcCtD
Proguanil—Headache—Doxorubicin—breast cancer	4.9e-05	0.000387	CcSEcCtD
Proguanil—Nausea—Doxorubicin—breast cancer	4.65e-05	0.000367	CcSEcCtD
Proguanil—CYP2C9—Metabolism—PTGS1—breast cancer	4.81e-06	4.89e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.79e-06	4.87e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ABCB1—breast cancer	4.79e-06	4.87e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—IL6—breast cancer	4.77e-06	4.85e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOA3—breast cancer	4.74e-06	4.82e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.73e-06	4.81e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP2D6—breast cancer	4.72e-06	4.8e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC2A2—breast cancer	4.71e-06	4.79e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—TYMS—breast cancer	4.7e-06	4.78e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA4—breast cancer	4.7e-06	4.78e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CA9—breast cancer	4.7e-06	4.78e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NQO1—breast cancer	4.68e-06	4.76e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SLC2A1—breast cancer	4.68e-06	4.76e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NCOA2—breast cancer	4.67e-06	4.75e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.66e-06	4.74e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NCOR1—breast cancer	4.65e-06	4.73e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PLA2G4A—breast cancer	4.65e-06	4.73e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTM1—breast cancer	4.65e-06	4.73e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NCOA2—breast cancer	4.63e-06	4.71e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CPT1A—breast cancer	4.61e-06	4.69e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCG2—breast cancer	4.61e-06	4.69e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—MTR—breast cancer	4.61e-06	4.69e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.58e-06	4.66e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GPX2—breast cancer	4.58e-06	4.65e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA2—breast cancer	4.58e-06	4.65e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP3A4—breast cancer	4.56e-06	4.64e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.54e-06	4.62e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—FASN—breast cancer	4.53e-06	4.61e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HPGDS—breast cancer	4.52e-06	4.6e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GPX4—breast cancer	4.52e-06	4.6e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SULT1A1—breast cancer	4.52e-06	4.6e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—BCHE—breast cancer	4.51e-06	4.59e-05	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CA—breast cancer	4.51e-06	4.59e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HBA1—breast cancer	4.49e-06	4.57e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—FASN—breast cancer	4.49e-06	4.57e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP1B1—breast cancer	4.49e-06	4.56e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—BCHE—breast cancer	4.47e-06	4.55e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC5A5—breast cancer	4.46e-06	4.53e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GPX1—breast cancer	4.45e-06	4.53e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC5A5—breast cancer	4.42e-06	4.49e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA1—breast cancer	4.42e-06	4.49e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—IDH1—breast cancer	4.42e-06	4.49e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP1A1—breast cancer	4.41e-06	4.48e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—HSP90AA1—breast cancer	4.4e-06	4.47e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—AKT1—breast cancer	4.4e-06	4.47e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTT1—breast cancer	4.39e-06	4.46e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ACHE—breast cancer	4.39e-06	4.46e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ERCC2—breast cancer	4.37e-06	4.44e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NAT2—breast cancer	4.37e-06	4.44e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SLC2A1—breast cancer	4.3e-06	4.38e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NQO1—breast cancer	4.3e-06	4.38e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NCOA1—breast cancer	4.28e-06	4.35e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NQO1—breast cancer	4.27e-06	4.34e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SLC2A1—breast cancer	4.27e-06	4.34e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—STK11—breast cancer	4.22e-06	4.29e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP19A1—breast cancer	4.22e-06	4.29e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP3A4—breast cancer	4.2e-06	4.27e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.18e-06	4.25e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP3A4—breast cancer	4.16e-06	4.23e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP17A1—breast cancer	4.15e-06	4.22e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.14e-06	4.21e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP1B1—breast cancer	4.13e-06	4.2e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ENO1—breast cancer	4.11e-06	4.18e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS1—breast cancer	4.11e-06	4.18e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—MTHFR—breast cancer	4.11e-06	4.18e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.1e-06	4.16e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP1B1—breast cancer	4.09e-06	4.16e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.05e-06	4.11e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.04e-06	4.11e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP2D6—breast cancer	4.03e-06	4.1e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—HSP90AA1—breast cancer	4.01e-06	4.08e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.96e-06	4.03e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOA2—breast cancer	3.96e-06	4.02e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NCOA1—breast cancer	3.94e-06	4e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—COMT—breast cancer	3.92e-06	3.99e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTP1—breast cancer	3.9e-06	3.97e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NCOA1—breast cancer	3.9e-06	3.97e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—STK11—breast cancer	3.88e-06	3.94e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP19A1—breast cancer	3.88e-06	3.94e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—HMOX1—breast cancer	3.85e-06	3.91e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP19A1—breast cancer	3.85e-06	3.91e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—STK11—breast cancer	3.85e-06	3.91e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ITPR1—breast cancer	3.84e-06	3.9e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—FASN—breast cancer	3.84e-06	3.9e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—DPYD—breast cancer	3.83e-06	3.89e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MED12—breast cancer	3.83e-06	3.89e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—BCHE—breast cancer	3.82e-06	3.89e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CAV1—breast cancer	3.79e-06	3.85e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC5A5—breast cancer	3.77e-06	3.84e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALDOA—breast cancer	3.77e-06	3.83e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ABCB1—breast cancer	3.69e-06	3.76e-05	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKT1—breast cancer	3.68e-06	3.75e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOA3—breast cancer	3.66e-06	3.72e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NQO1—breast cancer	3.65e-06	3.71e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SLC2A1—breast cancer	3.65e-06	3.71e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC2A2—breast cancer	3.63e-06	3.69e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—TYMS—breast cancer	3.63e-06	3.69e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.61e-06	3.67e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—COMT—breast cancer	3.61e-06	3.67e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTP1—breast cancer	3.59e-06	3.65e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTM1—breast cancer	3.59e-06	3.65e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.59e-06	3.65e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NCOR1—breast cancer	3.59e-06	3.65e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—COMT—breast cancer	3.57e-06	3.64e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.57e-06	3.63e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CPT1A—breast cancer	3.56e-06	3.62e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MTR—breast cancer	3.56e-06	3.62e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCG2—breast cancer	3.56e-06	3.62e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTP1—breast cancer	3.56e-06	3.62e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP3A4—breast cancer	3.56e-06	3.62e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—HMOX1—breast cancer	3.54e-06	3.6e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.54e-06	3.6e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ITPR1—breast cancer	3.53e-06	3.59e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—HMOX1—breast cancer	3.51e-06	3.57e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ITPR1—breast cancer	3.5e-06	3.56e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP1B1—breast cancer	3.5e-06	3.55e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HPGDS—breast cancer	3.49e-06	3.55e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HBA1—breast cancer	3.47e-06	3.53e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CG—breast cancer	3.45e-06	3.51e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GPX1—breast cancer	3.43e-06	3.49e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HSP90AA1—breast cancer	3.43e-06	3.49e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP1A1—breast cancer	3.4e-06	3.46e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ABCB1—breast cancer	3.4e-06	3.46e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTT1—breast cancer	3.39e-06	3.44e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ACHE—breast cancer	3.39e-06	3.44e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ERCC2—breast cancer	3.37e-06	3.43e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ABCB1—breast cancer	3.37e-06	3.43e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—TYMS—breast cancer	3.34e-06	3.39e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOA1—breast cancer	3.33e-06	3.39e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TYMS—breast cancer	3.31e-06	3.36e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTM1—breast cancer	3.3e-06	3.35e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.3e-06	3.35e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NCOR1—breast cancer	3.3e-06	3.35e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—STK11—breast cancer	3.29e-06	3.34e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP19A1—breast cancer	3.29e-06	3.34e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTM1—breast cancer	3.27e-06	3.33e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.27e-06	3.33e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NCOR1—breast cancer	3.27e-06	3.33e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP17A1—breast cancer	3.2e-06	3.26e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ENO1—breast cancer	3.17e-06	3.23e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS1—breast cancer	3.17e-06	3.23e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—MTHFR—breast cancer	3.17e-06	3.22e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GPX1—breast cancer	3.16e-06	3.21e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GPX1—breast cancer	3.13e-06	3.18e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP1A1—breast cancer	3.13e-06	3.18e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP2D6—breast cancer	3.11e-06	3.16e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ERCC2—breast cancer	3.1e-06	3.15e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP1A1—breast cancer	3.1e-06	3.15e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.08e-06	3.14e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ERCC2—breast cancer	3.07e-06	3.13e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—COMT—breast cancer	3.05e-06	3.11e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOA2—breast cancer	3.05e-06	3.11e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTP1—breast cancer	3.04e-06	3.09e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CD—breast cancer	3.03e-06	3.09e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HMOX1—breast cancer	3e-06	3.05e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ALB—breast cancer	3e-06	3.05e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ITPR1—breast cancer	2.99e-06	3.04e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—FASN—breast cancer	2.96e-06	3.01e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—BCHE—breast cancer	2.95e-06	3e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CAV1—breast cancer	2.92e-06	2.97e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—MTHFR—breast cancer	2.91e-06	2.96e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC5A5—breast cancer	2.91e-06	2.96e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—MTHFR—breast cancer	2.89e-06	2.94e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCB1—breast cancer	2.88e-06	2.93e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NOS3—breast cancer	2.86e-06	2.91e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TYMS—breast cancer	2.83e-06	2.87e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SLC2A1—breast cancer	2.81e-06	2.86e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NQO1—breast cancer	2.81e-06	2.86e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTM1—breast cancer	2.79e-06	2.84e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOR1—breast cancer	2.79e-06	2.84e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.79e-06	2.84e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.79e-06	2.84e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP1B1—breast cancer	2.7e-06	2.74e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CAV1—breast cancer	2.69e-06	2.73e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GPX1—breast cancer	2.68e-06	2.72e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CAV1—breast cancer	2.67e-06	2.71e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CG—breast cancer	2.66e-06	2.71e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP1A1—breast cancer	2.65e-06	2.69e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.65e-06	2.69e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CB—breast cancer	2.64e-06	2.69e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ERCC2—breast cancer	2.63e-06	2.67e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTGS2—breast cancer	2.62e-06	2.66e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOA1—breast cancer	2.57e-06	2.62e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.55e-06	2.59e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—STK11—breast cancer	2.54e-06	2.58e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP19A1—breast cancer	2.54e-06	2.58e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—MTHFR—breast cancer	2.47e-06	2.51e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CG—breast cancer	2.45e-06	2.49e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CG—breast cancer	2.43e-06	2.47e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—COMT—breast cancer	2.36e-06	2.4e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTP1—breast cancer	2.35e-06	2.39e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CD—breast cancer	2.34e-06	2.38e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HMOX1—breast cancer	2.31e-06	2.35e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ALB—breast cancer	2.31e-06	2.35e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ITPR1—breast cancer	2.31e-06	2.35e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTEN—breast cancer	2.29e-06	2.32e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CAV1—breast cancer	2.28e-06	2.32e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCB1—breast cancer	2.22e-06	2.26e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NOS3—breast cancer	2.21e-06	2.25e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TYMS—breast cancer	2.18e-06	2.22e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.18e-06	2.21e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOR1—breast cancer	2.16e-06	2.19e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.16e-06	2.19e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTM1—breast cancer	2.16e-06	2.19e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CD—breast cancer	2.15e-06	2.19e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CD—breast cancer	2.13e-06	2.17e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALB—breast cancer	2.13e-06	2.16e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALB—breast cancer	2.11e-06	2.14e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CG—breast cancer	2.07e-06	2.11e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GPX1—breast cancer	2.07e-06	2.1e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP1A1—breast cancer	2.04e-06	2.08e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CB—breast cancer	2.04e-06	2.07e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NOS3—breast cancer	2.03e-06	2.07e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ERCC2—breast cancer	2.03e-06	2.06e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTGS2—breast cancer	2.02e-06	2.06e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NOS3—breast cancer	2.02e-06	2.05e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MTHFR—breast cancer	1.91e-06	1.94e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CB—breast cancer	1.88e-06	1.91e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CB—breast cancer	1.86e-06	1.89e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTGS2—breast cancer	1.86e-06	1.89e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTGS2—breast cancer	1.84e-06	1.87e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CD—breast cancer	1.82e-06	1.85e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALB—breast cancer	1.8e-06	1.83e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTEN—breast cancer	1.76e-06	1.79e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CAV1—breast cancer	1.76e-06	1.79e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NOS3—breast cancer	1.72e-06	1.75e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTEN—breast cancer	1.62e-06	1.65e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CA—breast cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTEN—breast cancer	1.61e-06	1.63e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CG—breast cancer	1.6e-06	1.63e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CB—breast cancer	1.59e-06	1.62e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS2—breast cancer	1.58e-06	1.6e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CD—breast cancer	1.41e-06	1.43e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALB—breast cancer	1.39e-06	1.41e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTEN—breast cancer	1.37e-06	1.4e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NOS3—breast cancer	1.33e-06	1.35e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKT1—breast cancer	1.32e-06	1.34e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CA—breast cancer	1.24e-06	1.26e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CB—breast cancer	1.23e-06	1.25e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS2—breast cancer	1.22e-06	1.24e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CA—breast cancer	1.14e-06	1.16e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CA—breast cancer	1.13e-06	1.15e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTEN—breast cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKT1—breast cancer	1.02e-06	1.03e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CA—breast cancer	9.69e-07	9.86e-06	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKT1—breast cancer	9.35e-07	9.5e-06	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKT1—breast cancer	9.26e-07	9.42e-06	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKT1—breast cancer	7.92e-07	8.05e-06	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CA—breast cancer	7.48e-07	7.61e-06	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKT1—breast cancer	6.11e-07	6.21e-06	CbGpPWpGaD
